Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Aguilar, CristianBeltran, Brady E.
Morales, Domingo
Gutiérrez-Garibay, Marco
Villela, Luis
Marques-Piubelli, Mario L.
Vega, Francisco
Miranda, Roberto N.
Malpica, Luis
Issue Date
2023-05-01Keywords
Adult T-cell leukemia/lymphomacardiac valve
HTLV-1
mitral valve
Human T-cell Lymphotropic Virus Type 1 (HTLV-1)
Cardiac involvement
Cardiac valve infiltration
Mitral valve replacement
Histopathological evaluation
Foxp3 expression
Venous malformation
HTLV-1 serology
Smoldering ATLL
Watch and wait" strategy
Progressive heart failure
Metadata
Show full item recordPublisher
Elsevier Inc.Journal
Cardiovascular PathologyDOI
https://doi.org/10.1016/j.carpath.2022.107513Abstract
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive mature T-cell neoplasm caused by infection with the Human T-cell Lymphotropic Virus Type 1 (HTLV-1). Cardiac involvement in patients with ATLL is infrequent, and when it happens it is usually seen in aggressive ATLL subtypes. However, ATLL presenting as isolated cardiac valve involvement is extremely rare. To date, only three histologically proven cases of ATLL with isolated cardiac valve involvement have been reported. Herein, we describe a 61-year-old Peruvian man who presented heart failure symptoms secondary to progressive cardiac valve infiltration. The patient underwent mitral valve replacement with a mechanical prosthesis. Histopathological evaluation of the resected valve revealed leaflet thickening with a nodular appearance due to fibrous tissue containing atypical T-lymphocytes with Foxp3 expression, infiltrating all layers of the resected valve. Interestingly, tumor cells were distributed around an incidental venous malformation (i.e., cavernous hemangioma). Postoperative evaluation demonstrated positive serology for HTLV-1, and a diagnosis of ATLL was established. Postoperative positron emission tomography/computed tomography did not show lesions outside the heart and cell blood counts were within normal range with low level of circulating CD4+ CD25+ lymphoma cell counts (7%); therefore, patient's disease was considered as smoldering ATLL and a “watch and wait” strategy was pursued. Currently, the patient is alive with no progression of disease after 18 months from diagnosis. Isolated cardiac valve involvement by ATLL should be considered in the differential diagnosis of HTLV-1 carriers with progressive heart failure, even when systemic lymphoma involvement is absent or not apparent.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/embargoedAccessLanguage
engISSN
10548807EISSN
18791336ae974a485f413a2113503eed53cd6c53
https://doi.org/10.1016/j.carpath.2022.107513
Scopus Count
Collections
